Yaz Harms Contact An MDL Today 11-7-2012

Yaz, Yasmin, BeYaz and Ocella increase the risk of pulmonary embolism by 74%

Yaz and Yasmin were ranked second highest in 2011 for the number of complications reported to the FDA, (Food and Drug Administration) according to the QuarterWatch report from the Institute for Safe Medicine Practices.

Bayer, the manufacturer of Yaz and Yasmin has started settling some injury claims due to the use of Yaz and Yasmin at an average of $212,000 per case.

The Yaz Resource Center (a patient advocacy group) has been alerting women with questions about Yaz that the birth control drug has been linked to blood clot injuries.

Anyone affected by pulmonary embolism, blood clots, DVT or stroke after taking Yaz, Yasmin, BeYaz, or Ocella should contact a Multi-district Litigation Lawyer (MDL) who handles Yaz cases.

To contact a MDL attorney that represents women who have been harmed by Yaz, Yasmin, BeYaz or Ocella either fill out the form to your right, or visit our site at The Maher Law Firm

 

What Is Yaz | October 2012 Yasmin News Update

Yaz is a birth control pill or oral contraceptive that contains the synthetic female hormone, progesterone called “drospirenone”.

Drospirenone, is a dangerous drug that causes many adverse effects including, DVT (deep vein thrombosis) and blood clots which in turn can cause heart attack, stroke, pulmonary embolisms and even death.

Birth control pills containing drospirenone include:

Yaz, Yasmin, BeYaz, Ocella, Yasminelle, Zarah and Angeliq

Bayer AG, the manufacturer of yaz and yasmin announced settlements totaling over $400,000 U.S. dollars as of August 2012.  There have been at least 1,900 cases resolved claiming the birth control pills caused heart attacks and/or strokes.  Bayer AG, paid out an average of $212,000 U.S. dollars per case.

Birth control pills containing drospirenone are required to include the following information:

A summary of previously released results of the FDA funded study regarding the blood clot risk, and that some epidemiologic studies show as high as a threefold increased risk for blood clots for birth control pills containing drospirenone.

If you believe that you or a loved one has suffered injury or death due to a defective or dangerous pharmaceutical, you may have the right to compensation for your injuries.  The Maher Law Firm and Frank M. Eidson would like to help.  We invite you to contact our trial tested Yaz, Yasmin & Ocella Lawyers today.

Yaz Injury Claims

Were you harmed while taking, Yaz, Yasmin, Ocella or Beyaz

Yaz, Yasmin, Beyaz and Ocella are dangerous drugs used for the purpose of preventing pregnancy.  They contain a drug called “Drospirenone”.  According to the FDA women using birth control pills containing progestogen hormones drospirenone, desogestrel or gestodene are 75 percent more likely to develop blood clots compared to those who use “older-generation” pills.

Drospirenone has been linked to many serious adverse events, including, but not limited to:  Chest pain, pain in the arms or shoulders, nausea, swelling of the hands and ankles, breast lumps, depression, wheezing and migraine headaches – among other symptoms.

It has been noted that women who are otherwise completely healthy, have experienced adverse events while taking Yaz, Yasmin, Ocella or Beyaz.

Steve Maher of the Maher Law Firm is an appointed Yaz MDL (Multi-District Litigation) Lawyer.  He does not represent the drug companies, he does not represent the insurance companies, he represents you.

You have the right to trust your medication is safe.  Tragically, this is not always the case.  Well versed in the product liability laws that protect consumers, our Yaz Attorneys have handled countless lawsuits involving harmful pharmaceuticals.  If you or a loved one have experienced side effects as a result of Yaz, Yasmin, Ocella or Beyaz, contact our Yaz Lawyers today.

 

Yaz and Yazmin (Yasmin)

Yaz and Yazmin (Yasmin) are oral contraceptives (birth control pills) manufactured by Bayer Healthcare Pharmaceutical

Yasmin and Yaz are oral contraceptives (birth control pills) manufactured for the prevention of pregnancy.  Yasmin was approved by the FDA (Food and Drug Administration) in 2001, Yaz was approved by the FDA in 2006.  Yaz and Yasmin prevent pregnancy by combining estrogen and a synthetic progestin known as “drospirenone”.

Drospirenone is a dangerous drug.  According to the FDA birth control pills containing drospirenone may be associated with a significantly higher risk of blood clots or DVT (Deep Vein Thrombosis) than birth control pills that do not contain drospirenone.  Since blood clots move through the body, there may be a threefold increased risk for heart attack, stroke, pulmonary embolism and even death due to DVT.

Women who are otherwise completely healthy, have experienced injuries and side effects after taking Yaz, Yasmin or Ocella.  In fact, Yasmin and Yaz have been linked to fifty deaths and hundreds of injuries.

Yaz and Yasmin lawsuit settlements have reached $402 million, Bayer AG pays out an average of $212 thousand per Yaz and Yasmin case, and has put aside a reserve of $610.5 million to settle Yaz and Yasmin cases.

Steve Maher – an experienced MDL attorney represents women who have been harmed by Yaz, Yasmin and Ocella.  Steve does not represent drug manufacturers or insurance companies, Steve represents you and your loved ones.  If you or a loved one has suffered injury or even death as a result of Yaz, Yasmin or Ocella use, contact The Maher Law Firm for a free case evaluation.

What is Yaz, Yasmin?

Yaz and Yasmin are oral contraceptives that help prevent pregnancy by preventing ovulation (the release of an egg from an ovary)

Yaz and Yasmin can cause changes in your uterine lining and cervical lining.  This change make it harder for sperm to reach the uterus, therefore making it harder for a fertilized egg to attach to the uterus.

Yaz and Yasmin have been used to treat health problems as well, including, but not limited to:

  1. Moderate acne in women who are at least 14 years of age or older and who have started their menstrual periods, and symptoms of premenstrual dysphoric disorder (PMDD) including:

  • Anxiety
  • Depression
  • Irritability
  • Trouble Concentrating
  • Lack of Energy
  • Sleep or Appetite Change
  • Breast Tenderness
  • Joint or Muscle Pain
  • Headache
  • Weight Gain

Yaz and Yasmin contain estrogen (in the form of ethinyl estradiol) and Progestin (in the form of the synthetic hormone drospirenone)

The FDA (Food and Drug Administration) has concluded that birth control pills (Oral Contraceptives) containing Drospirenone have a 74% increased risk  for blood clots or venous thromboembolism.

Yaz and Yasmin have also been known to cause heart attacks, strokes, and deep vein thrombosis- just to name a few.

Yaz and Yasmin have been linked to 50 deaths in women as young as 17 and hundreds of injuries.

The FDA (Food and Drug Administration) has yet to issue a Yaz recall.

If you believe that you or a loved one has suffered injury or death due to a defective or dangerous pharmaceutical, you may have the right to compensation for your injuries.  The Maher Law Firm and Frank M. Eidson would like to help.  We invite you to contact our trial tested Yaz, Yasmin & Ocella Lawyers today.

FDA Warns Oral Contraceptives – Yaz, Yasmin – Have High Risk Of Blood Clots

Oral contraceptives that contain drospirenone have a threefold increase for risk of blood clots

The FDA (Food and Drug Administration) “has concluded that drospirenone containing birth control pills may be associated with a higher risk for blood clots than other progestin containing pills.”

Nine oral contraceptives containing 3mg of drospirenone and either 0.02 or 0.03 mg of ethinyl estradiol, will now note the risk of blood clots on their labels.  The oral contraceptives include:  Yaz, Yasmin, Ocella, Zarah, Beyaz, Gianvi, Syeda, Loryna, Safyral.

If you believe that you or a loved one has suffered injury or death due to a defective or dangerous pharmaceutical, you may have the right to compensation for your injuries.  The Maher Law Firm and Frank M. Eidson would like to help.  We invite you to contact our trial tested Yaz, Yasmin & Ocella Lawyers today.

Yaz Update: Bayer May Have Illegally Marketed Birth Control Pills

According to an online news article posted to Bloomberg’s website this week, it seems that pharmaceutical giant, Bayer AG, could have misled women regarding the potential health risks associated with use of their newer generation of birth control pills. Moreover, based on information collected from the review of internal company e-mails, Bayer may have even sought to market the Yasmin family of oral contraceptives for uses not previously approved by the FDA.

Internal documents provided to lawyers representing women suing Bayer revealed that unit officials within the company discussed promoting the birth control pill, Yaz (a spinoff of Yasmin), as a treatment for all types of premenstrual syndrome (PMS). However, to date, federal regulators have only approved Yaz as a treatment for the most severe form of PMS.

Within the documents, an e-mail message was uncovered which cited an article in Woman’s Day magazine about Yaz. The message, which read, “This article is a nice way of using YAZ for PMS treatment instead of just focusing on the specific class of women battling premenstrual dysphoric disorder, the most severe form of PMS,” was included in a mountain of internal files produced as evidence in ongoing litigation against Bayer.

At the moment, Bayer faces more than 10,000 lawsuits over injuries associated with use of their birth control pills, which allegedly caused women to suffer from blood clots, heart attacks and strokes. The U.S. Food and Drug Administration has even reported that approximately 50 deaths can be tied to Bayer’s pills between the years 2004 and 2008.

The overall safety regarding the Yasmin family of birth control pills continues to be the subject of heated, worldwide debate. Additionally, after reviewing the results collected from extensive research on the pills, the FDA released a statement last month warning that women taking these newer generation oral contraceptives are 74 percent more likely to suffer blood clots then women taking older generation pills.

In January, Bayer is set to face the first of what could be several trials of lawsuits in which Yasmin and Yaz are alleged to have caused serious injury. Many people hold the opinion that the Bayer and its business units have routinely sacrificed the safety and health of women who use their birth control pills, simply to increase the company’s bottom line profits. More than 12 million women in the U.S. and more than 100 million women worldwide use oral contraceptives, and as such, determining the overall safety and efficacy of these products is of the utmost importance.

BMJ Study Confirms Yaz Significantly Increases Clotting Risks

On October 25, 2011, The British Medical Journal published a study confirming previous findings that newer-generation birth control pills, specifically those containing the progestogen hormones drospirenone, desogestrel or gestodene, double the risk for venous thromboembolism (VTE), compared to older-generation contraceptives containing the progestogen hormone, levonorgestrel. Widely-used and incredibly popular brands like as Yasmin, Yaz and Ocella are all examples of the types of birth control pills currently under intense scrutiny by the U.S. Food and Drug Administration, as well as other regulatory agencies and watchdog groups.

The study, which was led by Dr. Ojvind Lidegaard of the University of Copenhagen, included approximately 1.2 million non-pregnant women between the ages of 15 and 49 with no previous history of thrombotic disease. The results revealed that women taking older-generation birth control pills were three times more likely to develop VTE, compared to those not taking any hormonal contraceptive. Alarmingly, however, women taking drospirenone-containing birth control pills were at six to seven times the risk for VTE compared to non-users. The data undoubtedly confirms that women taking newer-generation birth control pills are at an increased risk for developing potentially serious and even life-threatening blood clots.

VTE is a blood clot that forms deep within a leg vein, and can be especially dangerous (even deadly) if the clot travels to the heart, brain or lungs. Women taking a drospirenone-containing birth control pills, should be aware of the warning signs of VTE, which include continuous and severe leg pain, severe chest pain or shortness of breath.

FDA Study Suggests Yaz and Other Drospirenone-Contaning Birth Control Pills More Likely to Cause Blood Clots

The U.S. Food and Drug Administration recently issued an updated safety communication regarding Bayer Pharmaceutical’s widely-used birth control pills, Yaz and Yasmin, citing that women using these drugs are 75 percent more likely to develop blood clots compared to those who use older-generation pills.

As a result of the FDA’s study, which followed 800,000 women between the years 2001 and 2007, researchers from the FDA, Kaiser Permanente, Vanderbilt University and the University of Washington ultimately found that drospirenone-containing birth control pills increased the risk of blood clots, otherwise known as venous thromboembolic events (VTE), by 75 percent over pills containing progestin levonorgestrel.

Additionally, the study’s findings backed several claims raised by thousands of women who have filed Yaz-related lawsuits, all of whom experienced serious blood clots as a result of using drospirenone-containing birth control pills like Yaz, Yasmin, Beyaz, Gianvi, Loryna, Safyral, Syeda Zarah and/or Ocella.

The FDA will present the new data at a December 8th meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee.

FDA Still Concerned About Drospirenone-Containing Birth Control Pills

The U.S. Food and Drug Administration today posted a drug safety communication on their website, announcing that preliminary results of an agency-funded study involving 800,000 women suggest a 1.5-fold increase in the risk of blood clots for those women using drospirenone-containing birth-control pills, compared to those taking other forms of hormonal contraceptives. The popular and controversial brands Yaz and Yasmin, both products of Bayer AG, are prime examples of the type of drospirenone-containing pills currently under scrutiny by federal regulators.

While the FDA has yet to reach a final conclusion that drospirenone-containing pills raise the risk for blood clots beyond that of other pills, the regulatory agency still remains greatly concerned over the potentially fatal side effects linked to use of birth control pills that contain drospirenone. At present, conflicting information from a number of published studies regarding the blood-clot risk associated with drospirenone, has prompted the FDA to convene an outside panel of medical experts in order to further discuss the issue.

According to drug manufacturer, Bayer, available scientific evidence shows that the risk for developing blood clots as a result of taking birth-control pills containing drospirenone is “comparable” to that of other pills studied, but the company is still working with the FDA on the matter.